<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02604641</url>
  </required_header>
  <id_info>
    <org_study_id>Q10 01-2014</org_study_id>
    <nct_id>NCT02604641</nct_id>
  </id_info>
  <brief_title>Assessment of the Impact of a Coenzyme Q10 Supplementation on the Skin</brief_title>
  <official_title>Assessment of the Impact of a Coenzyme Q10 Supplementation on the Skin: Randomised, Double-blind, Placebo-controlled Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Higher School of Applied Sciences (VIST)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Valens Int. d.o.o., Slovenija</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nutrition Institute, Slovenia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Higher School of Applied Sciences (VIST)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective of the study is to determine the influence of dietary supplementation with coenzyme
      Q10 (CoQ10) on skin conditions. 33 healthy female subjects will be randomly assigned to a
      placebo group, a low-dose (LD) group receiving 50 mg CoQ10/day and a high-dose group (HD)
      receiving 150 mg CoQ10/day (11 subjects per group). A water-soluble form of CoQ10 with
      improved bioavailability (Quvital syrup with Q10vital®, Valens Int. d.o.o., Slovenia) will be
      used. Various skin parameters will be evaluated before the supplementation (the baseline),
      after 6 and after 12 weeks of supplementation. To evaluate the photoprotective potential of
      CoQ10 the minimal erythema dose (MED) will be determined before (the baseline) and after 12
      weeks of the supplementation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective of the study is to determine the influence of dietary supplementation of CoQ10 in
      form of water-soluble Q10vital® on skin conditions. 33 healthy female subjects will be
      randomly assigned to a placebo group, a low-dose (LD) group receiving 50 mg CoQ10/day and a
      high-dose group (HD) receiving 150 mg CoQ10/day (11 subjects per group). A water-soluble form
      of CoQ10 with improved bioavailability (Quvital syrup with Q10vital®, Valens Int. d.o.o.,
      Slovenia) will be used. The placebo or CoQ10 will be administered in the form of a syrup; all
      subjects will consume 5 mL of syrup daily for 12 weeks. The photoprotective potential of
      CoQ10 will be evaluated with a determination of the minimal erythema dose (MED) before (the
      baseline) and after 12 weeks of the supplementation. Other skin parameters will be evaluated
      before supplementation (the baseline), after 6 and after 12 weeks of supplementation.
      Comparison will be done as the mean of the individual ratios. The differences between the
      before-after condition will be analyzed with the statistical test of analysis of variance. In
      case of failure to find homogeneity in the variances the nonparametric ANOVA, the Willcoxon
      test, will be used. The results will be expressed as mean ± standard error for each group
      with a significance level of 0.05 for all the statistical tests.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement of photoprotective function of the skin</measure>
    <time_frame>after 12 weeks of the supplementation</time_frame>
    <description>Minimal erythema dose (MED) of the skin will be determined. Skin on gluteal part of the body will be exposed to 10 different doses of UVB light and 24 hours after exposure MED will be determined.Higher MED indicates better photoprotective function of the skin.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction of the area of the periorbital facial wrinkles</measure>
    <time_frame>after 6 and after 12 weeks of the supplementation</time_frame>
    <description>Area of selected periorbital wrinkles will be quantitatively assessed using CSI programme.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of the volume of the periorbital facial wrinkles</measure>
    <time_frame>after 6 and after 12 weeks of the supplementation</time_frame>
    <description>Volume of selected periorbital wrinkles will be quantitatively assessed using CSI programme.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of wrinkles at different face areas</measure>
    <time_frame>after 6 and after 12 weeks of the supplementation</time_frame>
    <description>Expert assessment of wrinkles at different face areas (periorbital, frontal, glabelar, nasolabial areas etc.) will be done according to Lemperle Wrinkle assessment scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of the dermis structure</measure>
    <time_frame>after 6 and after 12 weeks of the supplementation</time_frame>
    <description>Ultrasound (US) images of the dermis will be taken and intensity of the dermis determined. Higher intensity of the dermis US images indicates improvement of the collagen and elastin network.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>An increase of the dermis thickness</measure>
    <time_frame>after 6 and 12 weeks of the supplementation</time_frame>
    <description>Dermis thickness will be measured with ultrasound imaging of the skin.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Wrinkles</condition>
  <condition>Ageing</condition>
  <condition>Photoprotection</condition>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0 mg CoQ10 daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Quvital LD group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>50 mg CoQ10 daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Quvital HD group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>150 mg CoQ10 daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo group</intervention_name>
    <description>Subjects will take 5 mL of placebo syrup (0 mg CoQ10/day) once per day for 12 weeks.</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Quvital LD group</intervention_name>
    <description>Subjects will take 5 mL of LD syrup (50 mg CoQ10/day) once per day for 12 weeks.</description>
    <arm_group_label>Quvital LD group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Quvital HD group</intervention_name>
    <description>Subjects will take 5 mL of LD syrup (150 mg CoQ10/day) once per day for 12 weeks.</description>
    <arm_group_label>Quvital HD group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signs of skin aging (mimic wrinkles/ poor skin tone/ visual dryness),

          -  Photoaged skin on the face,

          -  Expression of mimic wrinkles,

          -  Phototype II and III.

        Exclusion Criteria:

          -  Allergy to ingredients of tested products

          -  High blood cholesterol and use of cholesterol-lowering medicines,

          -  Diagnosed diabetes

          -  Thyroid disease

          -  Inflammatory skin diseases,

          -  Regular use of dietary supplements 6 months or less before start of the study,

          -  Invasive rejuvenation treatments (botox injections, hyaluronic acid fillers, needle
             rollers, needle mesotherapy, etc.) 6 months or less prior to start of the study,

          -  Non-invasive rejuvenation treatments (radiofrequency, electrotherapy, ultrasound
             therapy, no-needle mesotherapy, etc.) 6 months or less prior to start of the study,

          -  The use of cosmetic products containing coenzyme Q10 6 months or less prior to start
             of the study,

          -  Gluteal hyperpigmentation,

          -  Expected sunbathing (also in solariums) within the study period.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Janko Zmitek, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Higher School of Applied Sciences (VIST)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Katja Zmitek, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Higher School of Applied Sciences (VIST)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Liljana Mervic, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>UL MF</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tina Tina Pogačnik, BSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Higher School of Applied Sciences (VIST)</affiliation>
  </overall_official>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 4, 2015</study_first_submitted>
  <study_first_submitted_qc>November 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2015</study_first_posted>
  <last_update_submitted>March 7, 2016</last_update_submitted>
  <last_update_submitted_qc>March 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>skin rejuvenation</keyword>
  <keyword>anti-ageing effects</keyword>
  <keyword>minimal erythema dose</keyword>
  <keyword>dermis structure</keyword>
  <keyword>physiological skin condition</keyword>
  <keyword>wrinkling</keyword>
  <keyword>dry skin</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coenzyme Q10</mesh_term>
    <mesh_term>Ubiquinone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

